Nanoscaffold matrices for size-controlled, pulsatile transdermal testosterone delivery: nanosize effects on the
Ritu Malik1, Shailesh Tondwal, K S Venkatesh
1Pharmaceutics Division, Central Drug Research Institute, Chattar Manzil Palace, Lucknow, 226001, India.
Abstract:
Pulsatile transdermal testosterone (T) has applications in hormone supplementation and male contraception. Pulsatile T delivery was achieved by assembling crystalline and nanoparticulate T in nucleation-inhibiting polymer matrices of controlled porosity. Different interference patterns observed from various polymeric films containing T were due to the various particle sizes of T present in the polymer matrices. Scanning electron microscopy was used to determine the size and shape of T crystals. Skin-adherent films containing T nanoparticles of any size between 10-500 nm could be prepared using pharmaceutically acceptable vinylic polymers. Drug release and skin permeation profiles were studied. The dissolution-diffusion behavior of nanoparticles differed from crystalline and molecular states. Nanosize may thus be used to engineer chronopharmacologically relevant drug delivery.
Related Concept Videos
Transdermal Drug Delivery Systems
Factors Affecting Dissolution: Particle Size and Effective Surface Area


